Keyphrases
Mouse Model
100%
Treatment Dose
100%
Chronic Myeloid Leukemia
100%
Gonadotoxic
100%
Nilotinib
100%
Leukemia Therapy
100%
Spermatogenesis
66%
Folliculogenesis
50%
Female Mice
33%
Tyrosine Kinase Inhibitor
16%
Deleterious Effects
16%
Histological Parameters
16%
Male Infertility
16%
Drinking Water
16%
Follicle number
16%
Spermatogenic Activity
16%
Female Subfertility
16%
Medicine and Dentistry
Chronic Myelogenous Leukemia
100%
Nilotinib
100%
Spermiogenesis
66%
Ovary Follicle Development
50%
Body Weight
16%
Tyrosine-Kinase Inhibitor
16%
Follicle
16%
Female Subfertility
16%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Chronic Myeloid Leukemia
100%
Nilotinib
100%
Protein Tyrosine Kinase Inhibitor
16%
Female Subfertility
16%